Everything Innovation. Everything New Jersey.
Follow us and stay connected.
Somerset, NJ - According to Emily Bader of NJBiz, "Catalent announced it has formed an advisory board to structure the development of its biologics business. The Somerset-based provider of advanced technologies said in a news release that the founding members of its advisory board are Carolyn Bertozzi, Barry Buckland, Michael Buckley, Daniel R. Marshak and Edward R. Robinson.
“This new board brings diverse expertise in biologics development and commercialization, new technologies, contract services and a deep understanding of the key challenges facing biologics developers, both now and in the future,” commented Mike Riley, Vice President and General Manager of Catalent Biologics. He added “Catalent Biologics has developed a unique combination of proprietary technology platforms and integrated services to enable our partners’ next generation of biologics treatments. These expert advisors will play a key role in guiding our strategy as we continue to build our biopharma solutions offerings.”
Do not miss a single innovative moment and sign up for our newsletter!